Clinical Trial Update: Intranasal Oxytocin in Youth With Autism [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating intranasal oxytocin in youth with autism. The study status is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Autism Spectrum Disorder

Drugs mentioned

• Oxytocin (intranasal) (oxytocin)

Snippet

Sponsor: Oslo University Hospital | Conditions: Autism Spectrum Disorder | Phase 2 | Status: NOT_YET_RECRUITING